Head-to-head · Cost-Efficiency Index
Andrew Meds vs boostAGErx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Andrew Meds
Shoppers comparing published monthly rates who are willing to check that the price on the page is the price the checkout charges.
Visit Andrew MedsboostAGErx
Cost-sensitive shoppers prepaying 12 months for low-cost GLP-1.
Visit boostAGErxThe verdict
Andrew Meds takes it, leading the Cost-Efficiency Index 70 to 69. Andrew Meds publishes $199 semaglutide and $299 tirzepatide on its product pages, then sends every Get Started button to an intake that sells a $99 low-dose program and never offers tirzepatide at all. boostAGErx still earns a C — Cost-sensitive shoppers prepaying 12 months for low-cost GLP-1.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Andrew Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Andrew Meds | boostAGErx |
|---|---|---|
| Cost-Efficiency Index | 70/100 | 69/100 |
| Semaglutide / mo | $199/month month-to-month (the intake this page opens sells a $99 low-dose program instead) | $95/mo (billed every 28 days, compounded) |
| Tirzepatide / mo | $299/month month-to-month | $145/mo (billed every 28 days, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $1,140 |
| Tirzepatide / yr (modeled) | $3,588 | $1,740 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #90 | #96 |
Andrew Meds
70/100Where the value is
- Full month-to-month and prepay ladders for both molecules are printed on the product pages, before any intake
- States which pharmacy class fills a prescription — "a 503(A) compounding pharmacy or 503(B) outsourcing facility" — which most sellers at this price leave unsaid
- Names the prescribing practice, with a street address and a direct phone line, in the footer of every page
The tradeoffs
- Three live semaglutide prices disagree: $199 a month on the product page, $99 a month in the intake that page links to, and $149 for a four-week supply in a second funnel
- The tirzepatide page's own funnel offers only semaglutide, so the $299 tirzepatide price cannot be bought through the route the page provides
boostAGErx
69/100Where the value is
- Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
- Free shipping and clinical evaluation included
- Membership fee refunded in full if you're not approved
The tradeoffs
- Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
- The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.